Argoman Startup Studio | AI Venture Factory

Medisense

Medisense is a cutting-edge diagnostic intelligence platform that utilizes machine learning to detect Tuberculosis (TB) through the non-invasive analysis of acoustic biomarkers. By processing the unique signatures found in a patient's cough and voice patterns, Medisense provides a rapid, high-precision screening solution designed for early-stage detection and large-scale public health monitoring.

Medisense serves as a centralized powerhouse for respiratory screening, aggregating acoustic data and transforming it into queryable health insights. The platform utilizes advanced analytics to extract digital biomarkers from vocal and pulmonary sounds, turning a simple audio recording into a comprehensive diagnostic profile. Clinicians and health workers can interact with the system to gain immediate clarity, asking questions such as:

Does this cough pattern align with known acoustic signatures of pulmonary Tuberculosis?

What is the probability of TB infection based on the patient's vocal frequency and cough duration?

How has the acoustic profile of this patient changed over the course of their treatment?

Harnessing the power of scalable cloud algorithms to detect diagnostic indicators seamlessly.

Primary Users

Public health organizations, rural diagnostic clinics, and infectious disease specialists.

Secondary Users

Mobile health (mHealth) providers, occupational health services, and community screening programs.

Primary Users

Public health organizations, rural diagnostic clinics, and infectious disease specialists.

Secondary Users

Mobile health (mHealth) providers, occupational health services, and community screening programs.

Intended to democratize respiratory evaluation mechanics worldwide.

Pain Points

Traditional TB diagnostics often require sputum samples or imaging, which can be difficult to collect and process in remote areas.

Waiting for laboratory results leads to delayed treatment and increased community transmission.

Conventional screening tools require expensive equipment and specialized laboratory facilities.

Millions of at-risk individuals lack access to centralized diagnostic centers.

Key Features

Acoustic Biomarker Engine – A specialized machine learning system trained to identify the unique temporal and spectral patterns of TB-related coughs.

Voice Profile Analysis – Analyzes vocal fold vibrations and airflow characteristics for early signs of respiratory distress.

Real-Time Diagnostic Dashboard – Provides an immediate risk score and clinical summary upon audio submission.

Longitudinal Monitoring – Tracks changes in the patient's acoustic signature over time to monitor treatment efficacy.

Offline-Capable Edge Processing – Allows for high-precision screening in remote environments with limited internet connectivity.

Value Proposition

Medisense transforms sound into a life-saving diagnostic signal. By automating the extraction of acoustic biomarkers, the platform enables:

Identify high-risk individuals in seconds using a standard microphone or smartphone.

Detect subtle changes in respiratory patterns before severe symptoms manifest.

Deploy high-precision screening across large populations without the need for physical reagents or heavy laboratory infrastructure.

Unlocking simple diagnostics for vulnerable and remote segments globally.